Genes & biomarkers
KIT variants
KIT · CD117 · GIST
KIT protein positivity and a KIT gene variant are different findings.
Sources checked · Introductory guide
On this page
What does this result mean?
KIT transmits growth and survival signals. Some gastrointestinal stromal tumors (GIST) carry KIT variants. CD117/KIT protein staining and gene testing provide different information.[1]
How does it connect to treatment?
Imatinib is used for selected KIT-positive GIST after surgery or in unresectable/metastatic disease. The specific alteration and previous treatments also inform drug choice.[2]
What should I check in my report?
Check whether the result refers to protein staining or gene testing. Review the exact exon/variant and other results such as PDGFRA; ask about resistance testing if the disease progresses.
Questions for your care team
- Is my result KIT protein positivity or a confirmed KIT variant?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- MedlinePlus Genetics · KIT (opens in a new tab)
- NCI · Imatinib (opens in a new tab)
- NCI · GIST Treatment (PDQ) (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.